Effect of mebendazole on melanoma xenograft growth through targeting of bcl-2

被引：0
|
作者：
Doudican, N. A. [1 ]
Pennell, R. [1 ]
Tu, T. [1 ]
Liebes, L. [1 ]
Pavlick, A. [1 ]
Berman, R. [1 ]
Shapiro, R. [1 ]
Goldberg, J. D. [1 ]
Osman, I. [1 ]
Orlow, S. [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9075
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting the Bcl-2 family for cancer therapy
    Thomas, Shibu
    Quinn, Bridget A.
    Das, Swadesh K.
    Dash, Rupesh
    Emdad, Luni
    Dasgupta, Santanu
    Wang, Xiang-Yang
    Dent, Paul
    Reed, John C.
    Pellecchia, Maurizio
    Sarkar, Devanand
    Fisher, Paul B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (01) : 61 - 75
  • [42] Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
    Nancy S. Younis
    Amal M. H. Ghanim
    Sameh Saber
    Scientific Reports, 9
  • [43] Therapeutics targeting Bcl-2 in hematological malignancies
    Ruefli-Brasse, Astrid
    Reed, John C.
    BIOCHEMICAL JOURNAL, 2017, 474 : 3643 - 3657
  • [44] Targeting the Bcl-2 family in cancer therapy
    Papadopoulos, Kyriakos
    SEMINARS IN ONCOLOGY, 2006, 33 (04) : 449 - 456
  • [45] Progress in targeting the BCL-2 family of proteins
    Garner, Thomas P.
    Lopez, Andrea
    Reyna, Denis E.
    Spitz, Adam Z.
    Gavathiotis, Evripidis
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2017, 39 : 133 - 142
  • [46] Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
    Younis, Nancy S.
    Ghanim, Amal M. H.
    Saber, Sameh
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
    U. Leiter
    R. M. Schmid
    P. Kaskel
    R. U. Peter
    G. Krähn
    Archives of Dermatological Research, 2000, 292 : 225 - 232
  • [48] Targeting AML through apoptosis activation using Bcl-2/Mcl-1 or Bcl-2/Hdm2 inhibitor combination therapies
    Wang, Youzhen
    Qui, Shumei
    Sanghavi, Sneha
    Mulford, Lain
    Lysiak, Gaelle
    Chanrion, Maia
    Mistry, Prakash
    Pfaar, Ulrike
    Schoumacher, Marie
    Claperon, Audrey
    Kraus-Berthier, Laurence
    Banquet, Sebastien
    Derreal, Alix
    Fabre, Claire
    Maacke, Heiko
    Colland, Frederic
    Geneste, Olivier
    Morris, Erick
    Halilovic, Ensar
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
    Leiter, U
    Schmid, RM
    Kaskel, P
    Peter, RU
    Krähn, G
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2000, 292 (05) : 225 - 232
  • [50] CTCE-9908 INDUCES APOPTOSIS IN XENOGRAFT PROSTATIC TUMORS THROUGH KNOCK DOWN OF BCL-2
    Sakamoto, Noboru
    Rosser, Charles J.
    Porvasnik, Stacy
    Cao, Wengang
    Urbanek, Cydney
    Goodison, Steve
    Wong, Donald
    JOURNAL OF UROLOGY, 2009, 181 (04): : 395 - 395
12345